BNP/PUT/AMGEN/250/0.1/20.12.24 | Delayed Deutsche Boerse AG 12:51:01 26/06/2024 pm IST | ||
| 0.37 EUR | -2.63% |
|
| Current month | -38.71% | ||
| 1 month | -36.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 0.37 | -2.63% |
| 25/24/25 | 0.38 | -7.32% |
| 24/24/24 | 0.41 | -18.00% |
| 21/24/21 | 0.5 | -5.66% |
| 20/24/20 | 0.53 | +15.22% |
Delayed Quote Deutsche Boerse AG
Last update June 26, 2024 at 12:51 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| WKN | PN6Z73 |
| ISIN | DE000PN6Z738 |
| Date issued | 11/08/2023 |
| Strike | 250 $ |
| Maturity | 20/12/2024 (178 Days) |
| Parity | 10 : 1 |
| Emission price | 1.68 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.42 € |
|---|---|
| Lowest since issue | 0.34 € |
| Delta | -0.11x |
| Omega | 8.210 |
| Premium | 23.01x |
| Gearing | 76.43x |
| Moneyness | 0.7829 |
| Difference Strike | -69.31 $ |
| Difference Strike % | -27.72% |
| Spread | 0.02 € |
| Spread % | 5.00% |
| Intrinsic value | 0.000000 |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Warrants
- Warrant
